CVS Group Regulatory News (CVSG)

7 October 2015

CVS Group plc

("CVS" or the "Company")

Exercise of Options, Total Voting Rights and Director Dealing

CVS, the UK's leading provider of integrated veterinary services, announces that on 6 October 2015, Simon Innes, Chief Executive Officer of the Company, together with certain other employees of the Company, exercised options at 0.2 pence per share over an aggregate of 634,900 ordinary shares of 0.2 pence each in the Company (the "New Shares"), under the CVS Group Long Term Incentive Plan 2012/2015. Simon Innes exercised options over 301,020 ordinary shares of 0.2p each in the Company ("Ordinary Shares").

Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing ordinary shares, to be admitted to trading on AIM which is expected to occur on or about 8 October 2015.

Following the issue of the New Shares, the Company's total issued share capital will consist of 59,838,382 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following the issue of the New Shares, the total number of voting rights in the Company will be 59,838,382. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

On 6 October 2015, the Company was notified that, on that date, Simon Innes sold 301,020 Ordinary Shares at a price of 680p per Ordinary Share. Following the exercise and the sale, Simon Innes remains interested in 246,475 Ordinary Shares in the Company, representing 0.41 per cent of the total voting rights of the Company following the issue of the New Shares.

Contacts: